×
About 19,718 results

ALLMedicine™ Prostatectomy Center

Research & Reviews  6,769 results

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02933255

May 20th, 2022 - Background: Immune checkpoint inhibitors interfere with the immune system s autoregulatory mechanisms, allowing for a potentially expanded and prolonged T-cell response with the possibility of greater antitumor effects. Nivolumab is a fully human ...

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03976843

May 20th, 2022 - Background: About 30,000 men will die from prostate cancer in the US in 2018. The majority of these men originally presented with localized cancer. Treatment options for patients with high risk, localized disease typically involve radical prostate...

Fusion Guided Focal Laser Ablation of Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02759744

May 20th, 2022 - Background: Pilot study to evaluate the feasibility of real time ultrasound imaging to guide focal thermal ablation of low risk focal prostate tumors Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 t...

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03354416

May 20th, 2022 - Background: Multiparametric MRI (mpMRI) has become an established method for localizing clinically significant prostate cancer, and identification of imaging-based prognostic markers represents an active research area. Multiple treatments are avai...

Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
https://clinicaltrials.gov/ct2/show/NCT03253744

May 20th, 2022 - Background: Prostate cancer that recurs after prior radiation treatment can be challenging to cure due to the side effects of available treatments such as surgery and cryoablation. Re-irradiation with brachytherapy or stereotactic approaches has s...

see more →

Guidelines  12 results

Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of T...
https://doi.org/10.1016/j.ijrobp.2020.11.010
International Journal of Radiation Oncology, Biology, Phy... Robin S, Jolicoeur M et. al.

Nov 14th, 2020 - Prostate bed (PB) irradiation is considered the standard postoperative treatment after radical prostatectomy (RP) for tumors with high-risk features or persistent prostate-specific antigen, or for salvage treatment in case of biological relapse. F...

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of ...
https://doi.org/10.5858/arpa.2020-0015-RA
Archives of Pathology & Laboratory Medicine; Epstein JI, Amin MB et. al.

Jun 27th, 2020 - Controversies and uncertainty persist in prostate cancer grading. To update grading recommendations. Critical review of the literature along with pathology and clinician surveys. Percent Gleason pattern 4 (%GP4) is as follows: (1) report %GP4 in n...

Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 20...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680266
The Journal of Urology; Pisansky TM, Thompson IM et. al.

May 2nd, 2019 - The purpose of this amendment is to incorporate newly-published literature into the original ASTRO/AUA Adjuvant and Salvage Radiotherapy after Prostatectomy Guideline and to provide an updated clinical framework for clinicians. The original system...

ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
https://doi.org/10.1016/j.jacr.2018.03.019
Journal of the American College of Radiology : JACR; , Froemming AT et. al.

May 5th, 2018 - Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men ...

Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urol...
https://doi.org/10.1111/iju.13380
International Journal of Urology : Official Journal of Th... Kakehi Y, Sugimoto M et. al.

Jul 2nd, 2017 - These guidelines cover a wide range of topics from prostate cancer epidemiology to palliative care. Questions arising in daily clinical practice have been extracted and formulated as clinical questions. In the 4 years since the previous edition, t...

see more →

Drugs  58 results see all →

Clinicaltrials.gov  401 results

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03976843

May 20th, 2022 - Background: About 30,000 men will die from prostate cancer in the US in 2018. The majority of these men originally presented with localized cancer. Treatment options for patients with high risk, localized disease typically involve radical prostate...

Fusion Guided Focal Laser Ablation of Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02759744

May 20th, 2022 - Background: Pilot study to evaluate the feasibility of real time ultrasound imaging to guide focal thermal ablation of low risk focal prostate tumors Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 t...

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02933255

May 20th, 2022 - Background: Immune checkpoint inhibitors interfere with the immune system s autoregulatory mechanisms, allowing for a potentially expanded and prolonged T-cell response with the possibility of greater antitumor effects. Nivolumab is a fully human ...

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03354416

May 20th, 2022 - Background: Multiparametric MRI (mpMRI) has become an established method for localizing clinically significant prostate cancer, and identification of imaging-based prognostic markers represents an active research area. Multiple treatments are avai...

Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
https://clinicaltrials.gov/ct2/show/NCT03253744

May 20th, 2022 - Background: Prostate cancer that recurs after prior radiation treatment can be challenging to cure due to the side effects of available treatments such as surgery and cryoablation. Re-irradiation with brachytherapy or stereotactic approaches has s...

see more →

News  641 results

Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD
https://www.onclive.com/view/mount-sinai-welcomes-robotic-prostate-surgery-pioneer-mani-menon-md

Mar 1st, 2022 - Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Ed...

Darolutamide Demonstrates Strong Safety Profile in mCRPC after Long-Term Analyses
https://www.onclive.com/view/darolutamide-demonstrates-strong-safety-profile-in-mcrpc-after-long-term-analyses

Mar 1st, 2022 - Darolutamide (Nubeqa) produced a well-tolerated safety profile in patients with metastatic castration-resistant prostate cancer (mCRPC), according to pooled data from long-term analyses of 3 trials.1 The analysis from first author Egils Vjaters, ...

Patients With Urological Cancer and COVID-19 Undergoing Elective Surgery at Higher Risk for Mortality
https://www.onclive.com/view/patients-with-urological-cancer-and-covid-19-undergoing-elective-surgery-at-higher-risk-for-mortality

Mar 1st, 2022 - Patients with a urological cancer who were also infected with COVID-19 and undergoing elective surgery for their disease, were found to have a significantly higher likelihood of experiencing respiratory complications and mortality than those witho...

18F-rhPSMA-7.3 Imaging Favorable Detection Rates in Men with Recurrent Prostate Cancer
https://www.onclive.com/view/18f-rhpsma-7-3-imaging-favorable-detection-rates-in-men-with-recurrent-prostate-cancer

Feb 18th, 2022 - The utilization of 18F-rhPSMA-7.3 imaging displayed a clinically meaningful correct detection rate (CDR), meeting the prespecified threshhold of assessing suspected biochemical recurrence in prostate cancer, according to findings from the phase 3 ...

Beta-blocker use at surgery lowers prostate cancer recurrence risk
https://www.mdedge.com/fedprac/article/251837/prostate-cancer/beta-blocker-use-surgery-lowers-prostate-cancer-recurrence

Feb 15th, 2022 - Key clinical point: Use of nonselective beta-blockers at the time of radical prostatectomy is associated with a lower odds of treatment initiation for recurrence in patients with prostate cancer. Major finding: The use of nonselective beta-blocker.

see more →

Patient Education  6 results see all →